Get all your news in one place.
100's of premium titles.
One app.
Start reading
Euronews
Euronews
Gabriela Galvin

Novo Nordisk CEO steps down amid growing competition for weight loss drugs

Danish pharmaceutical giant Novo Nordisk is saying goodbye to its chief executive amid growing competition for its blockbuster weight loss drugs Wegovy and Ozempic.

Lars Fruergaard Jørgensen, who led the company for eight years, will step down due to “market challenges” and a drop in the company’s share price over the past year, Novo Nordisk said on Friday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.